Day: September 23, 2019

The provincial city of Cosenza, at the southern tip of Italy’s boot, is hardly one of the country’s metropolitan centers. But, amidst the town’s narrow streets, several low-THC cannabis shops are open for business. One of the most prominent is Cicileu, just a block off the Corso Mazzini, Cosenza’s main dragContinue Reading

Executives welcomed recommendations to improve the framework governing Australia’s medical cannabis scheme as a potential breakthrough, but some said the expected implementation of the proposals is “far too slow” for a sector in need of regulatory improvement today. The recommendations – made in a government-commissioned report authored by John McMillan, law professorContinue Reading

Learn more about how cannabis is helping fighters of endometriosis, and how research is catching up to anecdotal reports of its efficacy. The post Endometriosis Is Painful as Hell. At Least There’s Cannabis appeared first on Leafly. Read More: Endometriosis Is Painful as Hell. At Least There’s CannabisContinue Reading

State-licensed marijuana businesses need to adhere to federal labor laws governing paying overtime to employees, an appellate court ruled, which is a decision that could have broad implications for the MJ industry. A three-judge panel of the U.S. Court of Appeals for the Tenth Circuit in Denver affirmed a decision byContinue Reading

Wisconsin legislators introduce a medical legalization bill, while South Dakota activists float both medical and adult-use initiatives. The post Wisconsin and South Dakota Are Preparing 2020 Legalization Measures appeared first on Leafly. Read More: Wisconsin and South Dakota Are Preparing 2020 Legalization MeasuresContinue Reading

In this Executive Webcast on Sept. 26 at 2 p.m. ET, CEO Jessica Billingsley will join Investor Intelligence Analyst Mike Regan to discuss Akerna’s outlook and the role technology can play in addressing the current vape crisis. Exclusive webcast: Akerna CEO talks marijuana vape crisis, seed-to-sale outages is a post from: Marijuana BusinessContinue Reading

The European Commission granted marketing authorization to Epidyolex, the trade name in Europe for Epidiolex, GW Pharmaceuticals announced Monday. In June 2018, the U.S. Food and Drug Administration approved Epidiolex for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet syndrome in patients two years of age and older. The CBD-basedContinue Reading